Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2022

Sep 1, 2022

29821_dirs_2022-09-01_a1b13865-07fb-4d7e-a10a-c0f56cc48952.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2022-05-02

Reporting Person: Sorenson John Bradley (EVP, Global Operations)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-02 Restricted Stock Units $ A 16814.0000 Acquired 2026-05-02 Common Stock (16814.0000) Direct

Footnotes

F1: Each restricted stock unit represents the Company's committment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.